S&P 500 slips, but losses kept in check as Nvidia climbs ahead of results
On Tuesday, Cantor Fitzgerald analysts initiated coverage on Braze Inc (NASDAQ: NASDAQ:BRZE), assigning the stock an Overweight rating. The analysts set a price target of $45.00, citing a favorable risk/reward ratio despite macroeconomic challenges. According to InvestingPro data, 13 analysts have recently revised their earnings estimates upward for the upcoming period, with price targets ranging from $38 to $75.
The analysts highlighted Braze’s unique data platform and enterprise-grade technology as key strengths. They believe these features position the company to capture a significant portion of the estimated $30 billion total addressable market. The firm’s upmarket traction and investment in platform expansion and channel partner relationships are expected to drive further growth. This growth trajectory is already evident in the company’s impressive 25.78% revenue growth over the last twelve months, reaching $593.41 million. InvestingPro analysis reveals the company maintains strong liquidity, with current assets exceeding short-term obligations by a factor of 1.98x.
Cantor Fitzgerald’s report noted Braze’s ability to maintain a net revenue retention rate above 110%, thanks to significant cross-selling opportunities within its existing customer base. This strategy is expected to contribute to sustained strong growth.
The analysts also emphasized Braze’s success in achieving robust incremental margins amid rapid growth. They forecast the company’s operating margins to reach 7.3% by fiscal year 2027, representing a substantial improvement from fiscal year 2024.
Overall, Cantor Fitzgerald’s initiation with an Overweight rating reflects confidence in Braze’s growth potential and strategic initiatives in the current market environment.
In other recent news, Braze has completed its acquisition of OfferFit, an artificial intelligence decisioning company. This acquisition aims to enhance Braze’s customer engagement capabilities by integrating OfferFit’s machine learning technology. In terms of financial analysis, Citi has maintained a Buy rating for Braze with a $55 price target, citing steady execution and potential for growth. Similarly, Goldman Sachs reiterated its Buy rating with a $50 price target, noting Braze’s potential to gain market share despite broader market volatility. Stifel also maintains a Buy rating but has adjusted its price target to $45, reflecting insights from market trends and Braze’s business momentum.
Macquarie, on the other hand, has raised its price target slightly to $40, maintaining a neutral stance while acknowledging Braze’s impressive performance and strategic moves. The company has surpassed top-line expectations, with a 23% increase in calculated remaining performance obligations. Analysts from these firms are closely monitoring Braze’s integration of OfferFit and developments in Project Catalyst, which are expected to drive future growth. These recent developments highlight Braze’s strategic positioning and ongoing efforts to enhance its offerings in the market.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.